非移植符合条件的新诊断多发性骨髓瘤的挑战
Ioannis Ntanasis-Stathopoulos1, Eirini Solia1, Charalampos Filippatos1
1Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Leukemia & lymphoma
|September 30, 2025
概括
对于新诊断的多发性骨髓瘤患者,无法接受自身移植,强效的三倍或四倍方案显著改善了结果. 这些疗法减少了进展或死亡,并增加了最小的残留疾病负面影响,支持在这个人群中使用它们.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 自主移植资格对于多发性骨髓瘤治疗决策至关重要.
- 对于不适合移植的患者,最佳的第一线策略需要评估.
研究的目的:
- 对评估新诊断的多发性骨髓瘤患者的第一线治疗方案的随机研究进行元分析,这些患者不符合自身移植的条件.
- 评估现代三倍和四倍疗程的疗效和安全性.
主要方法:
- 随机对照试验的元分析.
- 系统的文献搜索,数据截止时间为2025年2月6日.
- 评估无进展生存率和最小残留疾病 (MRD) 的消极性.
主要成果:
- 三倍和四倍疗法显著降低了进展或死亡的风险 (危险比率 = 0.63).
- 这些疗法大约使得实现MRD负面性的几率增加了三倍 (几率比率=3.15).
- 治疗方案通常被很好地容忍.
结论:
- 强效的组合疗法,包括适合患者的四胞胎和适合中等患者的三胞胎,可用于新诊断的多发性髓瘤.
- 德甲节约疗法是脆弱个体的一个有价值的选择.
- 建议将脆弱性评估纳入研究中,以适应量身定制的治疗方法.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
相关概念视频
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tissue Transplantation
921
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
921
